Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 186-191 |
Number of pages | 6 |
Journal | Current Clinical Pharmacology |
Volume | 5 |
Issue number | 3 |
Publication status | Published - 2010 |
Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents.
S M Leijen, J.H. Beijnen, J.H.M. Schellens
Research output: Contribution to journal › Article › Academic › peer-review